Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

A less electrifying electronics expo

The Consumer Electronics Show in Las Vegas -- known in years past for its outsized booths, wall-to-wall crowds and lobster dinners -- is going to be a lot tamer next month. Other companies will...

Consumers now key to high tech's sales

As a result, technology that once took a decade or more to penetrate the mass market now takes far less time, said Kurt Scherf, principal analyst of Parks Associates in Dallas. The growth of wi...

More mainstream movies for Netflix online

Netflix Inc. moved one step closer to delivering on the promise its name implies: providing movies via the Internet. The Starz agreement helps to narrow that gap. Netflix subscribers who have u...

Area HDTV owners with cable service have limited choices

""In the last stages of Adelphia's existence, they were bleeding money," said analyst Kurt Scherf at Parks Associates, a consulting and research firm. "They were putting very little into infrastruc...

‹
1
2
3
4
5
6
7
8
9
10
›